Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Wayfair Inc (W) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Wayfair IncTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Wayfair Inc vs Zimmer Biomet Holdings Inc — how do they compare? Wayfair Inc trades at $103.59 (market cap $14.14B), while Zimmer Biomet Holdings Inc trades at $94.76 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is the larger of the two by market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals.

WZBH
Market Cap
$14.14B$18.55B
Sector
Consumer CyclicalHealth
52-Week High
$119.05$107.71
52-Week Low
$57.40$79.58
Enterprise Value
$16.47B$25.61B
Dividend Yield
0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Wayfair Inc

No Aura AI signal available yet.

Zimmer Biomet Holdings Inc

ZBH trades at $97.78, up 1.27% today, with a bullish technical outlook supported by moving averages and recent earnings beats. The company reported Q2 2026 EPS of $2.07, exceeding expectations, and raised its 2026 outlook. Revenue growth remains steady at 4.8% year-over-year, though net income margin has moderated from 2023 peaks. Analyst consensus is a 'Buy' with a $103.56 price target, indicating modest upside potential from current levels.

The stock offers a balanced risk-reward profile with solid fundamentals and positive momentum, but faces headwinds from margin pressure and rising debt levels. Investors should weigh the strong institutional support and consistent earnings performance against competitive pressures and macroeconomic uncertainties affecting the medtech sector.

Returns comparison

Trailing returns across standard periods

About Wayfair Inc

Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.

Read more on W

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH